- Home
- IBRX vs PDI Comparison
IBRX vs PDI Comparison
Compare IBRX & PDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBRX | PDI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.6B |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | IBRX | PDI |
|---|---|---|
| Price | $7.24 | $16.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.57 | N/A |
| AVG Volume (30 Days) | ★ 9.4M | 2.4M |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $88.59 | N/A |
| Revenue Next Year | $131.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $15.82 |
| 52 Week High | $12.43 | $20.05 |
Technical Indicators
Market Signals| Indicator | IBRX | PDI |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 39.68 |
| Support Level | $6.69 | N/A |
| Resistance Level | $8.46 | $16.79 |
| Average True Range (ATR) | 0.42 | 0.16 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 38.93 | 35.42 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About PDI PIMCO Dynamic Income Fund
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.